目的：分析低分子肝素钙联合硫酸镁与酚妥拉明治疗肺源性心脏病急性加重期的临床效果。方法随机选择2014年2月-2015年3月来该院治疗肺源性心脏病急性加重期患者70例，随机将其分成两组，每组35例。对照组患者采用对症治疗，治疗组患者在此基础上采用低分子肝素钙、硫酸镁与酚妥拉明共同治疗，观察两组患者治疗效果。结果治疗组患者治疗总有效率为100.00%明显高于与对照组患者的62.86%，差异有统计学意义(P<0.05)。结论在常规对症治疗基础上采用低分子肝素钙、硫酸镁与酚妥拉明共同治疗对改善临床症状、缓解病情有明显作用，可推广应用。%Objective To analyze the low molecular weight heparin calcium magnesium sulfate and treatment of pulmonary heart disease in acute exacerbation of the clinical effects of phentolamine. Methods February 2014 - March 2015 to our hospital with acute exacerbation of pulmonary heart disease 70 patients were randomly divided into two groups, each 35 cases. Symptomatic treatment of patients in the control group, patients treated on the basis of the use of low molecular weight heparin calcium, magnesium sulfate and phentolamine common therapy, therapeutic effects were observed two groups of patients. Results The total effective rate of treatment group was significantly higher than 62.86% 100.00% of the control group patients, the difference was statistically significant (P<0.05). Conclusion The low molecular weight heparin in the conventional symptomatic treatment, based on magnesium sulfate and phentolamine common treatment to improve clinical symptoms, alleviate the condition plays a significant role, it can be widely applied.
展开▼
